TREPPO, Elena
 Distribuzione geografica
Continente #
NA - Nord America 1.319
AS - Asia 1.044
EU - Europa 422
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 26
OC - Oceania 5
AN - Antartide 1
Totale 3.143
Nazione #
US - Stati Uniti d'America 1.252
SG - Singapore 505
CN - Cina 169
BR - Brasile 147
IT - Italia 125
VN - Vietnam 124
HK - Hong Kong 103
RU - Federazione Russa 58
FR - Francia 45
DE - Germania 42
CA - Canada 36
GB - Regno Unito 26
FI - Finlandia 24
IN - India 23
KR - Corea 23
BD - Bangladesh 19
AR - Argentina 14
IE - Irlanda 14
AT - Austria 13
PL - Polonia 13
JP - Giappone 12
NL - Olanda 12
PK - Pakistan 11
SE - Svezia 10
ZA - Sudafrica 10
ID - Indonesia 9
IQ - Iraq 9
CO - Colombia 7
UZ - Uzbekistan 7
ES - Italia 6
MX - Messico 6
BE - Belgio 5
LT - Lituania 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
EC - Ecuador 4
GR - Grecia 4
JM - Giamaica 4
NI - Nicaragua 4
TG - Togo 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
HR - Croazia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
OM - Oman 3
UA - Ucraina 3
AU - Australia 2
CH - Svizzera 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.000
Città #
Singapore 236
Ashburn 205
San Jose 138
Council Bluffs 105
Hong Kong 95
Beijing 73
Boardman 54
Los Angeles 37
Ho Chi Minh City 34
Lauterbourg 33
Santa Clara 32
Chandler 29
Dallas 26
New York 26
Hefei 25
Hanoi 23
Seoul 23
Milan 19
Redondo Beach 17
Frankfurt am Main 16
Helsinki 16
Phoenix 16
São Paulo 15
Buffalo 14
Dublin 14
North Bergen 13
The Dalles 13
Warsaw 13
Dong Ket 12
Nuremberg 12
Ann Arbor 11
Belluno 11
Denver 10
Houston 10
Tokyo 10
Wilmington 10
Düsseldorf 9
Seattle 9
Toronto 9
Woodbridge 9
Brooklyn 8
Lappeenranta 8
Montreal 8
Mumbai 8
Princeton 8
Stockholm 8
Udine 8
Amsterdam 7
Fairfield 7
London 7
Tashkent 7
Cambridge 6
Chicago 6
Johannesburg 6
Lahore 6
Ogden 6
Orem 6
Atlanta 5
Biên Hòa 5
Florence 5
Haiphong 5
Taranto 5
Vienna 5
Vilnius 5
Athens 4
Boston 4
Brussels 4
Charlotte 4
Chennai 4
Da Nang 4
Jakarta 4
Kingston 4
Lomé 4
Managua 4
Milltown 4
Newark 4
Rimini 4
San Francisco 4
Trieste 4
Xi'an 4
Bogotá 3
Campinas 3
Christchurch 3
Cleveland 3
Colombo 3
Crema 3
Des Moines 3
Guarulhos 3
Hải Dương 3
Jacksonville 3
Lucca 3
Memphis 3
Milwaukee 3
Querétaro 3
Quito 3
Rio de Janeiro 3
Rosario 3
Semarang 3
The Bronx 3
Vũng Tàu 3
Totale 1.761
Nome #
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 153
Sjögren's disease and systemic lupus erythematosus overlap syndrome as distinct entity at the crossroads of two autoimmune disorders: clinical characterisation from two Italian reference centres for both diseases 143
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 125
Rituximab induction and maintenance in ANCA-associated vasculitis: State of the art and future perspectives 124
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 123
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001–2017) 110
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 107
Systemic vasculitis: one year in review 2023 105
The impact of two different rituximab-based strategies in cryoglobulinaemic vasculitis secondary to Sjögren's disease: a monocentric cohort study 104
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 103
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 102
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak 101
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres 101
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis 96
Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis 95
Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases 94
Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren's Syndrome 90
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 88
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 88
Systemic vasculitis: one year in review 2024 85
Systemic vasculitis: one year in review 2022 79
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 78
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years 78
Rheumatologic manifestations of Hepatitis C Virus 75
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 75
Paraproteinemias Associated with Autoimmune Diseases 71
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis 69
Mass-Forming Variants in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Diagnostic Complexities in Granulomatous Disease. A Case Report 67
One year in review 2020: vasculitis 66
Systemic vasculitis: one year in review 2025 62
One year in review 2021: systemic vasculitis 61
The paradigm shift in ANCA-Associated vasculitis: Prime time for the complement targeting 58
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targets 50
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study 45
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literature 43
Systemic vasculitis: one year in review 2026 29
Totale 3.143
Categoria #
all - tutte 14.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 0 0 0 4 0 0 9 6 0 10 7 10
2022/202394 10 4 11 5 10 15 0 5 15 11 4 4
2023/202498 15 10 9 3 13 3 1 4 9 11 8 12
2024/2025839 14 73 44 28 35 31 83 69 118 61 143 140
2025/20261.542 150 165 129 114 247 149 144 44 73 103 134 90
2026/2027432 36 79 139 178 0 0 0 0 0 0 0 0
Totale 3.143